Altered physical state of p210(bcr-abl) in tyrphostin AG957-treated K562 cells

Anti-Cancer Drugs

Volumn 7, Issue 8, 1996, Pages 815-824

  Kaur, Gurmeet ^a   Sausville, Edward A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

chronic myelogenous leukemia; Grb2; tyrosine kinase inhibition

Indexed keywords

AG 957; ENZYME INHIBITOR; ONCOPROTEIN; PROTEIN TYROSINE KINASE; TYRPHOSTIN; UNCLASSIFIED DRUG;

ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL;

EID: 0029750057     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199611000-00001     Document Type: Article

References (38)

1. Konopka JB, Witte ON. Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Mol Cell Biol 1985; 5: 3116 23.
2. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and giemsa staining. Nature 1973; 243: 290-3.
3. de Klein A, van Kessel AG, Grosveld G, et al. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia. Nature 1982; 300: 765-7.
4. Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosweld G. Philadelphia chromosomal breakpoints are clustered within a limited region, Bcr, on chromosome 22. Cell 1984; 36: 93-9.
5. Konopka JB, Watanabe SM, Witte ON. An alteration of human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 1984; 37: 1035-42.
6. Lowenstein EJ, Daly RJ, Batzer AG, et al. The SH2 and SH3 domain containing protein Grb2 links receptor tyrosine kinases to Ras signaling. Cell 1992; 70: 431-42.
7. Buday L, Downward J. Epidermal growth factor regulates p21Ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell 1993; 73: 611-20.
8. Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA. Association of Sos, Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 1993; 363: 45-51.
9. Li N, Batzer A, Daly R, et al. Guanine nucleotide releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signaling. Nature 1993; 363: 85-8.
10. Gale NW, Kaplan S, Lowenstein EJ, Schlessinger J, BarSagi D. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature 1993; 363: 88-92.
11. Olivier JP, Raabe T, Henkemeyer M, et al. A Drosophila SH2-SH3 adapter protein implicated in coupling the sevenless tyrosine kinase to an activator of Ras guanine nucleotide exchange, Sos. Cell 1993; 73: 179-91.
12. Simmon MA, Dodson GS, Rubin GM. An SH3-SH2-SH3 protein is required for p21Ras activation and binds to sevenless and Sos proteins in vitro. Cell 1993; 73: 169-77.
13. Rozakis-Adcock McGlade J, Mbamalu G, Pellici G. Association of Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of Ras pathway by tyrosine kinases. Nature 1992; 360: 689-92.
14. Rozakis-Adcock M, Fernley R, Wade J, Pawson T, Bowtell, D. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator. Nature 1993; 363: 83-5.
15. bcr -abl tyrosine kinase. J Biol Chem 1994; 269: 15381-7.
16. Salcini AE, Mcglade J, Pelicci G, Nicoletti I, Pawson T, Pelicci PG. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Oncogene 1994; 9: 2827-36.
17. Ravichandran K, Lorenz U, Shoelson SE, Burakoff SJ. Interaction of Shc with Grb2 regulates association of Grb2 with mSos. Mol Cell Biol 1995; 15: 593-600.
18. Wang JK, Gao G, Goklfarb M. Fibroblast growth factor receptor have different signaling and mitogenic potentials. Mol Cell Biol 1994; 14: 181-8.
19. Sasaoka TD, Draznin JW, Leitner W, Langlois WJ, Olefsky JM. Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin like growth factor-1, and epidermal growth factor. J Biol Chem 1994; 269: 13689-94.
20. McGlade J, Cheng A, Pellici G, Pellici PG, Pawson T. Shc proteins are phosphorylated and regulated by v-src and v-fps protein tyrosine kinases. Proc Natl Acad Sci USA 1992; 89: 8869-73.
21. bcr-abl and Shc and Grb2 adapter proteins in hematopoietic cells permits growth factor receptor-independent link to Ras activation pathway. J Exp Med 1994; 179: 167-75.
22. Levitzki A. Tyrphostins: tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction. FASEB J 1992; 6: 3275-82.
23. Levitzki A, Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science 1995; 267: 1782-8.
24. Anafi M, Gazit A, Gilon C, Ben-Neriah Y, Levitzki A. Selective interaction of transforming and normal abl protein with ATP, tyrosine co-polymer substrate and tyrphostins. J Biol Chem 1992; 267: 4518-23.
25. bcr abl autokinase activity in K562 chronic myelogenous leukemia. Anti-Cancer Drugs 1994; 5: 213-22.
26. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976; 72: 420-8.
27. Laemmeli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
28. Cleveland DW, Fischer SG, Kirshner MW, Laemmli UK. Peptide mapping by linked proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem 1977; 252: 1102-6.
29. Aflalo E, Iftach S, Segal S, Gazit A, Priel E. Inhibition of Topoisomerase I activity by tyrphostin derivatives, protein tyrosine blockers: Mechanism of action. Cancer Res 1994; 54: 5138-42.
30. McWhirter JR, Debora L, Galasso L, Wang JYJ. A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-abl oncoproteins. Mol Cell Biol 1993; 13: 7587-95.
31. McWhirter JR, Wang JY. An actin-binding function contributes to transformation by the Bcr-abl oncoprotein of Philadelphia chromosome positive human leukemias. EMBO J. 1993; 12: 1533-46.
32. Puil L, Liu J, Gish G, et al. Bcr-abl oncoprotein bind directly to activators of the Ras signaling pathway. EMBO 1994; 13: 764-73.
33. Maru Y, Peters KL, Afar DEH, Shibuya M, Witte ON. Smithgall TE. Tyrosine phosphorylation of Bcr by FPS/FES protein tyrosine kinase induces association of Bcr with Grb2/Sos. Mol Cell Biol 1995; 15: 835-42.
34. Reuther GW, Fu H, Cripe LD, Collier RJ, Pendergest AM. Association of the protein kinases c-Bcr and Bcr-abl with proteins of the 14-3-3 family. Science 1994; 266: 129-33.
35. Brunmark A, Cadenas E. Redox and addition chemistry of quinoid compounds and its biological implications. Free Radical Biol Med 1989; 7: 435-77.
36. Hanzlik RP, Harriman SP, Frauenhoff MM. Govalent binding of benzoquinone to reduced ribonnclease, adduct structures and stoichiometry. Chem Res Toxicol 1994; 7: 177-84.
37. Stanwell G, Barke TR, Yuspa SH. The erbstatin analogue methyl 2,5-dihydroxy-cinnamate cross-links proteins and is cytotoxic to normal and neoplastic cells by a mechanism independent of tyrosine kinase inhibition. Cancer Res 1995; 55: 4950-6.
38. lck. J Biol Chem 1993; 268: 17545-653.